Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 3.970
-0.125 (-3.05%)
Dec 15, 2025, 4:48 PM CET
Genomtec Revenue
Genomtec had revenue of 4.00K PLN in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 15.00K, up 1,400.00% year-over-year. In the year 2024, Genomtec had annual revenue of 1,000.00.
Revenue (ttm)
15.00K
Revenue Growth
+1,400.00%
P/S Ratio
4,112.65
Revenue / Employee
576.92
Employees
26
Market Cap
61.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000.00 | - | - |
| Dec 31, 2023 | 1,000.00 | -39.00K | -97.50% |
| Dec 31, 2022 | 40.00K | -179.00K | -81.74% |
| Dec 31, 2021 | 219.00K | 199.00K | 995.00% |
| Dec 31, 2020 | 20.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Selvita | 373.90M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 90.41M |